Regular Article
Protection against TNF-Induced Liver Parenchymal Cell Apoptosis during Endotoxemia by a Novel Caspase Inhibitor in Mice

https://doi.org/10.1006/taap.2000.9035Get rights and content

Abstract

Excessive apoptotic cell death is implicated in a growing number of acute and chronic disease states. Caspases are critical for the intracellular signaling pathway leading to apoptosis. The aim of this investigation was to evaluate the efficacy and the mechanism of action of the novel caspase inhibitor CV1013 in a well-characterized model of TNF-induced apoptosis. Administration of 700 mg/kg galactosamine/100 μg/kg endotoxin (Gal/ET) induced hepatocellular apoptosis in C3Heb/FeJ mice as indicated by increased caspase-3 activity (706% above controls) and enhanced DNA fragmentation (3400% above controls) at 6 h. In addition, apoptosis was aggravated by the neutrophil-induced injury at 7 h (ALT activities: 4220 ± 960 U/L and 48 ± 4% necrosis). All animals died 8–12 h after Gal/ET treatment from shock and liver failure. A dose of 10 or 1 mg/kg of CV1013 administered three times (3, 4.5, and 5.5 h after Gal/ET) effectively prevented caspase-3 activation and parenchymal cell apoptosis at 6 h as well as the subsequent neutrophil-induced aggravation of the injury at 7 h after Gal/ET treatment. Animals treated with 10 mg/kg CV1013 survived for 24 h without liver injury. CV1013 reduced the processing of caspase-3 and caspase-8. This suggests that CV1013 may have inhibited the small amount of active caspase-8 generated at the receptor level. Because of the multiple amplification loops used to activate the entire caspase cascade, blocking the initial intracellular signal by CV1013 was highly effective in preventing apoptotic cell death. CV1013 has therapeutic potential for disease states with excessive apoptosis.

References (36)

  • H.J. Schlayer et al.

    Involvement of tumor necrosis factor in endotoxin-triggered neutrophil adherence to sinusoidal endothelial cells of mouse liver and its modulation in acute phase

    J. Hepatol.

    (1988)
  • M.L. Bajt et al.

    Protection against Fas receptor-mediated apoptosis in hepatocytes and nonparenchymal cells by a caspase-8 inhibitor in vivo: Evidence for postmitochondrial processing of caspase-8

    Toxicol. Sci.

    (2000)
  • Cai, S. X, Wang, Y, Huang, J. C, Guastella, J, Wu, Y, Xu, D, and, Drewe, J. 2000, CV1013, a novel, potent and...
  • J.G. Chosay et al.

    Neutrophil margination and extravasation in sinusoids and venules of the liver during endotoxin-induced injury

    Am. J. Physiol.

    (1997)
  • G.M. Cohen

    Caspases: The executioners of apoptosis

    Biochem. J.

    (1997)
  • M. Enari et al.

    Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis

    Nature

    (1996)
  • N.A. Essani et al.

    Transcriptional activation of vascular cell adhesion molecule-1 (VCAM-1) gene in vivo and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock

    J. Immunol.

    (1997)
  • Cited by (69)

    • The role of apoptosis in acetaminophen hepatotoxicity

      2018, Food and Chemical Toxicology
      Citation Excerpt :

      If this fact is overlooked and proper solvent controls are not included, then protective effects of caspase inhibitors against APAP toxicity can be observed (El-Hassan et al., 2003; Hu and Colletti, 2010), even in the verified absence of caspase activation (El-Hassan et al., 2003). However, as has been shown repeatedly, caspase inhibitors are readily absorbed and are highly effective within less than an hour during TNF- or Fas receptor-induced apoptosis (Bajt et al., 2000, 2001; Jaeschke et al., 1998, 2000) and therefore can be given right before the onset of the injury. Thus, in order to avoid the effect of DMSO on the oxidative metabolism of APAP, we generally treat animals 2–3 h after APAP (Gujral et al., 2002; Lawson et al., 1999; Jaeschke et al., 2006).

    • Diterpenoid trigonoreidon B isolated from Trigonostemon reidioides alleviates inflammation in models of LPS-stimulated murine macrophages and inflammatory liver injury in mice

      2018, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      The liver is the most affected organ during sepsis [4]. Proinflammatory cytokines especially tumor necrosis factor-alpha (TNF-α) produced by activated macrophages have been shown to contribute to liver destruction through apoptosis cell death [5]. TNF-α mediates hepatocyte injury via apoptosis induction by binding with its death TNF-α receptor, which leads to caspase activation [6].

    • Caspase Inhibition Prevents Tumor Necrosis Factor-α–Induced Apoptosis and Promotes Necrotic Cell Death in Mouse Hepatocytes in Vivo and in Vitro

      2016, American Journal of Pathology
      Citation Excerpt :

      However, in addition to hepatocytes, there are many nonparenchymal cells in the liver that also play important roles in hepatocyte injury. In the context of LPS/GalN-induced hepatocyte death, it is well established that LPS activates Kupffer cells to trigger the production and release of TNF-α, whereas GalN deletes UTP in hepatocytes to cause a transient block in transcription and protein synthesis resulting in NF-κb inhibition.26,41 Moreover, neutrophils are also known to be recruited to the liver sinusoids after LPS/GalN administration to aggravate liver injury.26,42

    • Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice

      2014, Toxicology Letters
      Citation Excerpt :

      While there was an abundant amount of procaspase-3 in the liver at every time point, there was no cleavage into the active caspase-3 fragment in any of the samples from LCA-treated animals. In contrast, high levels of caspase-3 activities (Fig. 3A) correlated with the presence of active caspase-3 fragments in galactosamine/endotoxin-treated mice used as a positive control (Jaeschke et al., 2000). We also examined TUNEL-positive cells during LCA feeding.

    • Current issues with acetaminophen hepatotoxicity - A clinically relevant model to test the efficacy of natural products

      2011, Life Sciences
      Citation Excerpt :

      In these models, apoptotic cell death of 20–30% of hepatocytes correlates with > 100-fold increase of caspase-3 activity (Bajt et al., 2000; Gujral et al., 2004; Jaeschke et al., 2000). Furthermore, pan caspase inhibitors completely prevent TNF- and Fas receptor-induced apoptosis (Bajt et al., 2000; Jaeschke et al., 2000) but have absolutely no effect on APAP toxicity (Jaeschke et al., 2006; Lawson et al., 1999; Williams et al., 2010b). The two manuscripts claiming protection with caspase inhibitors in vivo used a pretreatment regimen (El-Hassan et al., 2003; Hu and Colletti, 2010).

    View all citing articles on Scopus
    View full text